Sign up for Table of Contents Alerts.

Email this page

Print this page

Review

Mechanisms of MYC stabilization in human malignancies

Melissa R. Junttila and Jukka Westermarck

Purchase article for $19

Subscribe to this journal for $129/year

MYC is a pleiotropic transcription factor that has been linked to a diverse range of cellular functions, such as cell cycle regulation, proliferation, growth, differentiation and metabolism. Not surprisingly, aberrant MYC signaling has been observed in human cancers and MYC has been demonstrated to promote cell transformation and tumor progression. Here we discuss recent discoveries that have expanded our knowledge of MYC protein stability. In particular we focus on mechanisms that might explain the increased stability of MYC often observed in human cancers and cell lines. We also summarize our recent characterization of Cancerous inhibitor of PP2A (CIP2A(/KIAA1524)) as a protein that inhibits PP2A-mediated MYC dephosphorylation and proteolytic degradation. Finally, we discuss the potential relevance of mechanisms that regulate MYC stability for tumor formation in the context of cancer therapy.

Authors

Melissa R. Junttila

University of California Comprehensive Cancer Center; San Francisco, CA

Jukka Westermarck

University of Tampere; Tampere, Finland

Purchase article for $19

Subscribe to this journal for $129/year